SHIVA GUPTA to Benzimidazoles
This is a "connection" page, showing publications SHIVA GUPTA has written about Benzimidazoles.
Connection Strength
0.781
-
Delineation of MGMT Hypermethylation as a Biomarker for Veliparib-Mediated Temozolomide-Sensitizing Therapy of Glioblastoma. J Natl Cancer Inst. 2016 May; 108(5).
Score: 0.411
-
Discordant in vitro and in vivo chemopotentiating effects of the PARP inhibitor veliparib in temozolomide-sensitive versus -resistant glioblastoma multiforme xenografts. Clin Cancer Res. 2014 Jul 15; 20(14):3730-41.
Score: 0.370